Analyst Ratings for Karyopharm Therapeutics (KPTI) [Sells]

KPTI Rating Summary

KPTI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on KPTI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $17.33 (+198.9%) * Over Last 12-Mos
Rating Score: 6.9 / 10   Percentile Rank: 71%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/6/2021 JPMorgan Eric Joseph Downgrade Underweight
(Overweight)
N/A
(N/A)
7.82
(5.80)
-25.83% Details
2/27/2019 BofA Securities Ying Huang Downgrade Underperform
(Neutral)
5.00
(15.00)
4.87
(5.80)
19.1% Details
Like KPTI Ratings? Also take a look at REPL

KPTI Ratings News